CS193480B2 - Method of producing m-dioxane-5-methylamines and their pharmaceutically usable acid additive salts - Google Patents

Method of producing m-dioxane-5-methylamines and their pharmaceutically usable acid additive salts

Info

Publication number
CS193480B2
CS193480B2 CS738528A CS852873A CS193480B2 CS 193480 B2 CS193480 B2 CS 193480B2 CS 738528 A CS738528 A CS 738528A CS 852873 A CS852873 A CS 852873A CS 193480 B2 CS193480 B2 CS 193480B2
Authority
CS
Czechoslovakia
Prior art keywords
methylamines
dioxane
producing
pharmaceutically usable
acid additive
Prior art date
Application number
CS738528A
Other languages
Czech (cs)
English (en)
Inventor
Richard N Booher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to CS763448A priority Critical patent/CS193488B2/cs
Publication of CS193480B2 publication Critical patent/CS193480B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS738528A 1972-12-08 1973-12-10 Method of producing m-dioxane-5-methylamines and their pharmaceutically usable acid additive salts CS193480B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS763448A CS193488B2 (en) 1972-12-08 1976-05-24 Method of producing 2-/alpha-/substituted/aminobenzyl/-1,3-propendiels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (1)

Publication Number Publication Date
CS193480B2 true CS193480B2 (en) 1979-10-31

Family

ID=23214841

Family Applications (3)

Application Number Title Priority Date Filing Date
CS738528A CS193480B2 (en) 1972-12-08 1973-12-10 Method of producing m-dioxane-5-methylamines and their pharmaceutically usable acid additive salts
CS765892A CS222209B2 (en) 1972-12-08 1973-12-10 Method of making the m-dioxan-5-methylamine and their pharmaceutically utilisable addition salts with acids
CS738529A CS222208B2 (en) 1972-12-08 1973-12-10 Method of making the m-dioxan-5-methylamine and their pharmaceutically utilizable addition salts with the acids

Family Applications After (2)

Application Number Title Priority Date Filing Date
CS765892A CS222209B2 (en) 1972-12-08 1973-12-10 Method of making the m-dioxan-5-methylamine and their pharmaceutically utilisable addition salts with acids
CS738529A CS222208B2 (en) 1972-12-08 1973-12-10 Method of making the m-dioxan-5-methylamine and their pharmaceutically utilizable addition salts with the acids

Country Status (27)

Country Link
JP (2) JPS5734835B2 (hr)
AR (3) AR206306A1 (hr)
AT (2) AT332396B (hr)
BE (1) BE808340A (hr)
BG (4) BG21223A3 (hr)
CA (2) CA1014560A (hr)
CH (4) CH619219A5 (hr)
CS (3) CS193480B2 (hr)
CY (1) CY1017A (hr)
DD (3) DD115653A5 (hr)
DE (1) DE2361340C2 (hr)
DK (1) DK134717B (hr)
ES (4) ES421291A1 (hr)
FR (1) FR2209578B1 (hr)
GB (2) GB1455997A (hr)
HK (1) HK60479A (hr)
HU (2) HU168620B (hr)
IE (1) IE40226B1 (hr)
IL (1) IL43773A (hr)
KE (1) KE2976A (hr)
MY (1) MY8000064A (hr)
NL (1) NL7316839A (hr)
PH (2) PH15197A (hr)
SE (3) SE403377B (hr)
SU (4) SU578001A3 (hr)
YU (3) YU35447B (hr)
ZA (1) ZA739207B (hr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013169531A1 (en) * 2012-05-09 2013-11-14 Boehringer Ingelheim International Gmbh Methods for making oxetan-3-ylmethanamines
LV14983B (lv) * 2013-10-15 2015-06-20 Olainfarm, A/S Fenibuta ražošanas starpproduktu iegūšanas paņēmiens

Also Published As

Publication number Publication date
SE417196B (sv) 1981-03-02
YU36171B (en) 1982-02-25
CH619219A5 (en) 1980-09-15
IL43773A0 (en) 1974-03-14
YU318573A (en) 1981-06-30
DE2361340C2 (de) 1983-11-24
YU35447B (en) 1981-02-28
ZA739207B (en) 1975-07-30
PH15197A (en) 1982-09-17
SU648081A3 (ru) 1979-02-15
KE2976A (en) 1979-07-20
CH614439A5 (en) 1979-11-30
FR2209578A1 (hr) 1974-07-05
CS222208B2 (en) 1983-05-27
CY1017A (en) 1979-11-23
SE403377B (sv) 1978-08-14
BG21409A3 (bg) 1976-05-20
BG26205A4 (bg) 1979-02-15
MY8000064A (en) 1980-12-31
SE428378B (sv) 1983-06-27
JPS4987680A (hr) 1974-08-22
AT330773B (de) 1976-07-26
AR212012A1 (es) 1978-04-28
JPS5734835B2 (hr) 1982-07-26
DD115653A5 (hr) 1975-10-12
GB1455997A (en) 1976-11-17
ATA1026073A (de) 1975-10-15
DD110864A5 (hr) 1975-01-12
ATA1026173A (de) 1976-01-15
CA1024150A (en) 1978-01-10
SU663305A3 (ru) 1979-05-15
HU168763B (hr) 1976-07-28
ES421290A1 (es) 1976-07-01
HK60479A (en) 1979-08-31
AR212416A1 (es) 1978-07-14
DK134717C (hr) 1977-05-31
AR206306A1 (es) 1976-07-15
YU109380A (en) 1981-04-30
DD109625A5 (hr) 1974-11-12
NL7316839A (hr) 1974-06-11
ES421291A1 (es) 1976-07-01
SU587861A3 (ru) 1978-01-05
HU168620B (hr) 1976-06-28
CH605903A5 (hr) 1978-10-13
YU318473A (en) 1980-09-25
BE808340A (fr) 1974-06-07
IL43773A (en) 1979-05-31
IE40226B1 (en) 1979-04-11
ES444716A1 (es) 1977-05-16
JPS5742633B2 (hr) 1982-09-09
PH14923A (en) 1982-01-29
JPS4987681A (hr) 1974-08-22
BG21223A3 (bg) 1976-03-20
YU36020B (en) 1981-11-13
SU578001A3 (ru) 1977-10-25
CA1014560A (en) 1977-07-26
GB1455998A (en) 1976-11-17
BG22386A3 (bg) 1977-02-20
CH630914A5 (en) 1982-07-15
AU6321773A (en) 1975-06-05
SE7701796L (sv) 1977-02-17
DK134717B (da) 1977-01-03
IE40226L (en) 1974-06-08
SE7701795L (sv) 1977-02-17
ES444911A1 (es) 1977-09-01
AT332396B (de) 1976-09-27
CS222209B2 (en) 1983-05-27
DE2361340A1 (de) 1974-06-12
FR2209578B1 (hr) 1977-09-02

Similar Documents

Publication Publication Date Title
CS187390B2 (en) Method of producing novel derivatives of benzimidazol-2-carbamic acid
CS194176B2 (en) Method of producing derivatives of 7-acylaminocephalosporanic acid
CS187389B2 (en) Method of producing alkanolamine derivatives
MY7900008A (en) Derivatives of 7b-amino-cep hem-3-ol-4-carboxylic acids and process for their manufacture
CS173597B2 (en) Method of 6-aminopenicillic acid production
CS183696B2 (en) Method for producing derivatives of 3-methyl-delta up3-cephem-4-carboxylic acid
CS183686B2 (en) Method of producing 1-hydroxy-2-pyridones
CS182248B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
CS191212B2 (en) Method of producing lysergamides
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
CS193480B2 (en) Method of producing m-dioxane-5-methylamines and their pharmaceutically usable acid additive salts
CS190359B2 (en) Method of producing new derivatives of 6-aminopenicilanic acid
CS188251B2 (en) Method of producing 4-oxo-4h-pyrano-3,2-c-qunolin-2-carboxylic acids and salts thereof
CS189575B2 (en) Method of producing 7-aminocephalosporanic acids
CS188175B2 (en) Method of producing 15-substituted omega-nor-prostaglandins
YU36177B (en) Process for obtaining novel derivatives of aminoimidazoisoquinoline and salts thereof
CS183664B2 (en) Method of producing new derivatives of 4-chlor-5-sulphamoylantranilic acid
ZA734022B (en) Pharmaceutically useful compounds and methods of producing and using same
BG24663A3 (en) Method of preparing succinylsuccinic acid dieste s
CS178903B2 (en) Method of producing urethans
ZA73876B (en) New salts of acth-peptides and processes for their manufacture
CS185631B2 (en) Method of producing new 4-fluorcarbanilinomethylalkyldimethylamonium salts
JPS5373565A (en) Method of producing substituted 1*2*44 oxadiazolyllacetic acid and its salt
CS193019B2 (en) Method of producing 15alpha-methylene-4-estrene-17beta-ols
IL41268A (en) Process for preparing salts of alpha-d-glucose-1-phosphoric acid and products obtained